Heart Test Laboratories, Inc. (HSCS)
NASDAQ: HSCS · IEX Real-Time Price · USD
3.750
+0.090 (2.46%)
Jul 22, 2024, 10:04 AM EDT - Market open
Heart Test Laboratories Employees
Heart Test Laboratories had 12 employees as of April 30, 2023. The number of employees did not change compared to the previous year.
Employees
12
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,550
Profits / Employee
-$532,617
Market Cap
2.46M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Apr 30, 2023 | 12 | 0 | - |
Apr 30, 2022 | 12 | - | - |
Related Stocks
Company Name | Employees |
---|---|
cbdMD | 52 |
Helius Medical Technologies | 22 |
Tenon Medical | 21 |
Catheter Precision | 14 |
InMed Pharmaceuticals | 13 |
Cyclacel Pharmaceuticals | 12 |
Entero Therapeutics | 9 |
Phio Pharmaceuticals | 9 |
HSCS News
- 11 days ago - HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction - GlobeNewsWire
- 6 weeks ago - HeartSciences Regains Compliance with Nasdaq Listing Requirements - GlobeNewsWire
- 2 months ago - HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio - GlobeNewsWire
- 3 months ago - HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG - GlobeNewsWire
- 3 months ago - HeartSciences to Present at the LD Micro Invitational XIV Conference - GlobeNewsWire
- 4 months ago - HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients - GlobeNewsWire
- 4 months ago - HeartSciences Reports Third Quarter Fiscal 2024 Financial Results - GlobeNewsWire
- 4 months ago - HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes - GlobeNewsWire